Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia

Scott R. Penzak, Susan K. Chuck

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences